Are CYP17 genotypes a biomarker for ovarian cancer in patients with cancer history in their family?

Abstract

BRCA1 and BRCA2 genes are responsible for 5-10% of breast and ovarian cancer cases. However, the vast majority of ovarian and breast cancer cases do not display the hereditary form of the disease. Estrogen-metabolizing genes may also contribute to the predisposition of breast or ovarian cancer. Polymorphic variants of the estrogen-metabolizing gene, CYP17… (More)

Topics

  • Presentations referencing similar topics